BCL2 and hepatocellular carcinoma: During hepatocellular carcinoma induction, the expression of Bcl-2, a downstream target gene of p38MAPK, was decreased, disrupting the balance between Bax and Bcl-2, and leading to the relative overexpression of Bax, ultimately causing apoptosis in hepatocellular carcinoma cells.